GE HealthCare Technologies (GEHC) Current Deferred Revenue (2022 - 2026)

GE HealthCare Technologies has reported Current Deferred Revenue for 5 years, with the latest figure at $2.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue rose 13.98% year-over-year to $2.2 billion; the trailing twelve-month figure through Mar 2026 stood at $2.2 billion (up 13.98% YoY), and the FY2025 full-year result was $2.1 billion, up 7.82% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $2.2 billion, up from $2.1 billion in the prior quarter.
• The five-year high for Current Deferred Revenue was $2.7 billion in Q2 2025, with the low at $1.9 billion in Q1 2024.
• Historically, Current Deferred Revenue has averaged $2.1 billion across 5 years, with a median of $2.0 billion in 2023.
• Annual changes were most pronounced in 2023 — Current Deferred Revenue jumped 38.34% — and 2024, when it retreated 25.92%.
• GE HealthCare Technologies' Current Deferred Revenue stood at $1.9 billion in 2022, then surged by 38.34% to $2.6 billion in 2023, then dropped by 25.92% to $1.9 billion in 2024, then gained by 7.82% to $2.1 billion in 2025, then climbed by 2.77% to $2.2 billion in 2026.
• The last three Current Deferred Revenue figures came in at $2.2 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.0 billion (Q3 2025), per Business Quant data.